Annual report pursuant to Section 13 and 15(d)

Earnings Per Share (Tables)

v3.22.2.2
Earnings Per Share (Tables)
12 Months Ended
Jun. 30, 2022
Notes Tables  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

The following table reflects the calculation of basic and diluted earnings per share (in thousands, except per share amounts):

Year Ended June 30, 

2022

    

2021

    

2020

Earnings per share – basic:

Net earnings, including noncontrolling interest

263,099

 

139,585

 

229,296

Less net earnings (loss) attributable to noncontrolling interest

(8,952)

 

(825)

 

Net earnings attributable to Bio-Techne

$

272,051

$

140,410

$

229,296

Income allocated to participating securities

 

(121)

 

(86)

 

(224)

Income available to common shareholders

$

271,930

$

140,324

$

229,072

Weighted-average shares outstanding – basic

 

39,219

 

38,747

 

38,201

Earnings per share – basic

$

6.93

$

3.62

$

6.00

Earnings per share – diluted:

 

  

 

  

 

  

Net earnings, including noncontrolling interest

$

263,099

$

139,585

$

229,296

Less net earnings (loss) attributable to noncontrolling interest

(8,952)

(825)

Net earnings attributable to Bio-Techne

272,051

140,410

229,296

Income allocated to participating securities

 

(121)

 

(86)

 

(224)

Income available to common shareholders

$

271,930

$

140,324

$

229,072

Weighted-average shares outstanding – basic

 

39,219

 

38,747

 

38,201

Dilutive effect of stock options and restricted stock units

 

1,810

 

1,736

 

1,200

Weighted-average common shares outstanding – diluted

 

41,029

 

40,483

 

39,401

Earnings per share – diluted

$

6.63

$

3.47

$

5.82